Bob Cunard Bio

As an Operating Partner for HealthEdge, Bob currently serves as Chief Executive Officer of The Columbus Organization. He also supports the evaluation of investment opportunities for HealthEdge Fund III. Bob brings nearly three decades of experience in US pharmaceuticals from the perspectives of wholesaler, retailer, and manufacturer. Before joining HealthEdge, he was most recently CEO of Aurobindo Pharma USA, Inc., the largest subsidiary of Aurobindo Pharma Limited, an API and finished dosage form generic manufacturer headquartered in Hyderabad, India. During his tenure at Aurobindo, he led the company through five years of significant growth, achieving a 33% compound annual growth rate in the US business and contributing to a 15x increase in corporate market capitalization to $6 billion.